Aimed Bio Inc. (KOSDAQ:0009K0)

South Korea flag South Korea · Delayed Price · Currency is KRW
48,750
-100 (-0.20%)
At close: Apr 29, 2026
Market Cap3.03T
Revenue (ttm)47.28B +302.0%
Net Income5.02B
EPS101.00
Shares Out64.67M
PE Ratio603.25
Forward PE275.59
Dividendn/a
Ex-Dividend Daten/a
Volume129,983
Average Volume190,995
Open49,300
Previous Close48,850
Day's Range48,600 - 50,100
52-Week Range42,000 - 80,200
Betan/a
RSI42.80
Earnings DateApr 13, 2026

About Aimed Bio

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 0009K0
Full Company Profile

Financial Performance

Financial Statements